Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.6K
Overview
44.6K
Cancer Vaccines01:30

Cancer Vaccines

376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
The Central Dogma01:20

The Central Dogma

21.7K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
21.7K
Recombinant DNA01:09

Recombinant DNA

95.1K
Overview
95.1K
Viral Mutations00:36

Viral Mutations

32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Transgenic Plants02:50

Transgenic Plants

7.2K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
7.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

mRNA-based MRI contrast agent for precise diagnosis of glioma and pseudoprogression.

Cell biomaterials·2026
Same author

Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases.

Nature cancer·2026
Same author

mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression.

Nature biotechnology·2026
Same author

Same Pill, Different Impact - Reassessing the Efficacy of Nirmatrelvir-Ritonavir.

The New England journal of medicine·2026
Same author

Macrophages: Targets for next-generation cancer immunotherapy.

Cancer cell·2026
Same author

Immunological knowledge.

Nature immunology·2026

相关实验视频

Updated: Jul 8, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.3K

RNA疫苗:一个变革性的进步

Brian D Brown1, Anthony S Fauci2, Yasmine Belkaid3

  • 1Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Immunity
|December 13, 2023
PubMed
概括

诺贝尔奖认可了mRNA疫苗的快速开发,这对于阻止COVID-19大流行至关重要. 这一创新通过基础科学和技术改变了疫苗设计.

更多相关视频

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.5K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

相关实验视频

Last Updated: Jul 8, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.3K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.5K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

科学领域:

  • 生物技术是生物技术.
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学

背景情况:

  • 传统的疫苗开发时间表对于新出现的传染病,如SARS-CoV-2,是不够的.
  • 随着COVID-19的流行,人们迫切需要快速的疫苗解决方案.

研究的目的:

  • 为了承认基础研究,使得迅速的mRNA疫苗的创造.
  • 突出mRNA技术对疫苗设计和流行病应对的变革性影响.

主要方法:

  • 利用对信使RNA (mRNA) 功能的基本生物学见解.
  • 整合技术创新,以开发高效的疫苗平台.

主要成果:

  • 成功和快速开发针对SARS-CoV-2的mRNA疫苗.
  • 在阻止COVID-19大流行方面做出重大贡献.

结论:

  • mRNA疫苗技术代表了预防传染病的范式转变.
  • 诺贝尔奖庆祝科学发现和公共卫生技术进步的融合.